Qardio
 | |
| Company type | Private |
|---|---|
| Industry | Medical Devices |
| Founded | 2012 |
| Founders |
|
| Headquarters | , |
Number of locations | 3 |
Key people | |
| Products |
|
| Website | www |
Qardio, Inc. is an American technology company that specializes in heart health monitoring products. It was founded by Marco Peluso and Rosario Iannella in early 2012.[1][2]
Qardio's first product, QardioArm, is a wireless blood pressure monitor that connects with Apples's Health app; it received FDA 510K clearance in June 2014.[3]
At CES 2015, Qardio announced two new products, QardioBase – smart scale and body analyzer and QardioMD – a medical dashboard for doctors.[4] QardioBase became available for sale in November 2015.[5]
Qardio launched the second generation of its smart scale, Qardio Base 2, in September 2017.[6]
QardioCore ambulatory ECG/EKG monitor received CE marking in August 2017.[7]
Qardio was selected as "Small Business of the Year" at the 2018 Entrepreneur Awards by Consumer Tech Association.[8]
References
- ^ Benny Evangelista (11 January 2014). "Dad inspires app-linked blood pressure, heart monitors - San Francisco Chronicle". San Francisco Chronicle.
- ^ Megan Rose Dickey (8 January 2014). "QardioArm and QardioCore - Business Insider". Business Insider.
- ^ Aditi Pai (20 June 2014). "FDA clears Qardio's sleek, connected blood pressure device". MobiHealthNews.
- ^ Jeremy Horwitz (5 January 2015). "9to5Mac's CES 2015 sponsor Qardio offers first look at its new iPhone-connected health sensors". 9to5Mac.
- ^ "QardioBase Smart Scale and body composition analyzer now available just in time for the holidays". Android Guys. 17 November 2015.
- ^ Greg Barbosa (31 August 2017). "Qardio Launches New QardioBase with Improved Sensors and Wider Base". 9to5Mac.
- ^ "QardioCore receives CE Mark and launches commercially in the European Union and the UK". Get Qardio.
- ^ "CTA Honors Qardio, BenjiLock and Founder of Parkopedia as 2018 Innovation Entrepreneur Award Winners". www.cta.tech. Retrieved 2020-04-03.